Cargando…
Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer
Platelet-lymphocyte ratio (PLR) is a hematological parameter which is investigated as a biomarker for prognosis in patients with breast cancer. Due to the controversial results from previous studies, we performed a meta-analysis. Databases of PubMed, Embase and Web of Science were searched to identi...
Autores principales: | Zhu, Yanyun, Si, Wen, Sun, Qiong, Qin, Boyu, Zhao, Weihong, Yang, Junlan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352031/ https://www.ncbi.nlm.nih.gov/pubmed/27906679 http://dx.doi.org/10.18632/oncotarget.13714 |
Ejemplares similares
-
Lower Platelet-to-Lymphocyte Ratio Was Associated with Poor Prognosis for Newborn Patients in NICU
por: Tang, Yanfei, et al.
Publicado: (2022) -
Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma
por: Shi, Lihui, et al.
Publicado: (2016) -
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
por: Krenn-Pilko, S, et al.
Publicado: (2014) -
The effect and correlation of smoking with platelet indices, neutrophil lymphocyte ratio and platelet lymphocyte ratio
por: Pujani, Mukta, et al.
Publicado: (2021) -
Dynamic changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predicts breast cancer prognosis
por: Kim, Ju-Yeon, et al.
Publicado: (2020)